RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

164 hedge funds and large institutions have $1.46B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
+6
Holders Change %
+3.8%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
26
Increased
65
Reduced
39
Closed
20
Calls
$21.3M
Puts
$54.7M
Net Calls
-$33.3M
Net Calls Change
-$14.2M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.2M
2
DFO
Duquesne Family Office
New York
+$13.9M
3
AA
Alta Advisers
United Kingdom
+$12.9M
4
SPC
Slate Path Capital
New York
+$9.64M
5
Norges Bank
Norges Bank
Norway
+$9.55M

Top Sellers

1
FCM
Farallon Capital Management
California
-$49.6M
2
Millennium Management
Millennium Management
New York
-$18.5M
3
EA
Emerald Advisers
Pennsylvania
-$8.39M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$7.44M
5
PM
Prosight Management
Texas
-$5.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
GC
176
Guggenheim Capital
Illinois
– -$218K -2,314 Closed
Prudential Financial
177
Prudential Financial
New Jersey
– -$206K -2,186 Closed
MAM
178
Meeder Asset Management
Ohio
– -$34K -360 Closed
OIA
179
OneDigital Investment Advisors
Kansas
– -$25K -270 Closed
PHK
180
Point72 Hong Kong
Hong Kong
– -$16K -168 Closed
AA
181
AlphaMark Advisors
Kentucky
– -$11K -115 Closed
PCP
182
Proficio Capital Partners
Massachusetts
– -$10K -107 Closed
4 5 6 7
8